Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193063
Status:
COMPLETED
Last Update Posted:
2014-03-12
First Post:
2005-09-12
Brief Title:
Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 HER2 Positive Metastatic Breast Cancer
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-07
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-12
First Submit QC Date:
September 12 2005
Study First Post Date:
2005-09-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-03-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-10
Last Update Post Date:
2014-03-12
Last Update Post Date Type:
ESTIMATED